CVS Health Corporation (BVMF:CVSH34)

CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of BRL 539.56 billion. The enterprise value is 913.98 billion.

Market Cap	539.56B
Enterprise Value	913.98B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	Oct 22, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.37%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	87.74%
Float	1.27B

Valuation Ratios

The trailing PE ratio is 215.87 and the forward PE ratio is 11.51.

PE Ratio	215.87
Forward PE	11.51
PS Ratio	0.26
PB Ratio	1.38
P/TBV Ratio	n/a
P/FCF Ratio	16.09
P/OCF Ratio	11.11
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.75, with an EV/FCF ratio of 27.25.

EV / Earnings	365.67
EV / Sales	0.44
EV / EBITDA	9.75
EV / EBIT	17.01
EV / FCF	27.25

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 1.12.

Current Ratio	0.83
Quick Ratio	0.59
Debt / Equity	1.12
Debt / EBITDA	4.62
Debt / FCF	12.99
Interest Coverage	3.28

Financial Efficiency

Return on equity (ROE) is 0.58% and return on invested capital (ROIC) is 4.06%.

Return on Equity (ROE)	0.58%
Return on Assets (ROA)	2.50%
Return on Invested Capital (ROIC)	4.06%
Return on Capital Employed (ROCE)	6.24%
Revenue Per Employee	8.04M
Profits Per Employee	9,632
Employee Count	300,000
Asset Turnover	1.54
Inventory Turnover	18.54

Taxes

In the past 12 months, CVS Health has paid 13.22 billion in taxes.

Income Tax	13.22B
Effective Tax Rate	85.28%

Stock Price Statistics

The stock price has increased by +31.33% in the last 52 weeks. The beta is 0.48, so CVS Health's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	+31.33%
50-Day Moving Average	41.45
200-Day Moving Average	37.74
Relative Strength Index (RSI)	47.57
Average Volume (20 Days)	1,740

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.57

Income Statement

In the last 12 months, CVS Health had revenue of BRL 2.09 trillion and earned 2.50 billion in profits. Earnings per share was 1.98.

Revenue	2.09T
Gross Profit	278.73B
Operating Income	54.08B
Pretax Income	15.50B
Net Income	2.50B
EBITDA	78.62B
EBIT	54.08B
Earnings Per Share (EPS)	1.98

Balance Sheet

The company has 59.86 billion in cash and 435.69 billion in debt, giving a net cash position of -375.83 billion.

Cash & Cash Equivalents	59.86B
Total Debt	435.69B
Net Cash	-375.83B
Net Cash Per Share	n/a
Equity (Book Value)	389.63B
Book Value Per Share	306.03
Working Capital	-83.06B

Cash Flow

In the last 12 months, operating cash flow was 48.55 billion and capital expenditures -15.01 billion, giving a free cash flow of 33.54 billion.

Operating Cash Flow	48.55B
Capital Expenditures	-15.01B
Free Cash Flow	33.54B
FCF Per Share	n/a

Margins

Gross margin is 13.35%, with operating and profit margins of 2.59% and 0.12%.

Gross Margin	13.35%
Operating Margin	2.59%
Pretax Margin	0.74%
Profit Margin	0.12%
EBITDA Margin	3.77%
EBIT Margin	2.59%
FCF Margin	1.61%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 2.40%.

Dividend Per Share	1.00
Dividend Yield	2.40%
Dividend Growth (YoY)	3.41%
Years of Dividend Growth	5
Payout Ratio	722.81%
Buyback Yield	0.37%
Shareholder Yield	2.77%
Earnings Yield	0.46%
FCF Yield	6.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 21, 2022. It was a forward split with a ratio of 5.

Last Split Date	Nov 21, 2022
Split Type	Forward
Split Ratio	5

Scores

CVS Health has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.18
Piotroski F-Score	6